Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,421.82
(
-1.06%
)
US TECH 100
28,377.20
(
-1.44%
)
Dow Jones
49,634.63
(
-0.86%
)
Brent Oil
105.92
(
1.67%
)
Bitcoin
79,108.00
(
-2.41%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

tradero

Send PM Follow Ignore
Followers 31
Posts 1002
Boards Moderated 0
Alias Born 12/23/2009

tradero

Re: itsabouttime post# 267482

Wednesday, 06/29/2016 4:48:19 AM

Wednesday, June 29, 2016 4:48:19 AM

Post# of 347009
Isn't it te other way around? Shift MERCK - AZN

Planned studies include bavituximab in combination with pembrolizumab (AZN ?, it should be MERCK) in hepatocellular carcinoma,and durvalumab (MERCK?) in NSCLC
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote